Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of XL999 in Patients With Multiple Myeloma

This study has been terminated.
(Study was terminated due to cardiac toxicities in the subjects)
Sponsor:
Information provided by:
Symphony Evolution, Inc.
ClinicalTrials.gov Identifier:
NCT00304590
First received: March 16, 2006
Last updated: February 18, 2010
Last verified: February 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2007
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)